Header Website@2x.png

Micrima papers accepted for the Cambridge conference on breast cancer imaging

News

Micrima papers accepted for the Cambridge conference on breast cancer imaging

AdobeStock_280704253@2x.png

Micrima is pleased to announce they have just had 2 papers on our Radio-wave imaging technology MARIA™ accepted for the upcoming Cambridge conference on breast cancer imaging. These papers are;

The first presentation of final statistics from the completed study of this whole-breast, non-compressing modality which does not employ ionizing radiation.
From a total of 223 evaluable cases, 80 were confirmed as cancer by means of histology post-image guided biopsy. For these studies, MARIA™’s overall sensitivity was calculated as 75%; in pre-/peri-menopausal women, sensitivity was 71%; in post-menopausal, it was 77%; in women with dense breasts (BI-RADS c and d) it was 86%

The second paper discusses a commercial radio-wave breast imaging system (MARIA™, Micrima Limited, Bristol) modified to support triggered data capture in systolic and diastolic states as part of a multi-site symptomatic clinical trial

Come and see us at the Cambridge conference on breast imaging to find out more or check out the clinical information section of the website

Share

Latest news

AdobeStock_-5@2x.png

Micrima Limited expanding the team

Micrima are looking to expand the team with new roles and replacements for a member of the team who is retiring.

Group%2089%402x_edited.png